| scholarly article | Q13442814 |
| P2093 | author name string | P. H. Degen | |
| A. Sioufi | |||
| U. P. Geiger | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | analytical chemistry | Q2346 |
| biochemistry | Q7094 | ||
| organic chemistry | Q11351 | ||
| Diclofenac | Q244408 | ||
| P304 | page(s) | 293-298 | |
| P577 | publication date | 1975-09-01 | |
| 1975-09-03 | |||
| P1433 | published in | Journal of Chromatography | Q902558 |
| P1476 | title | Quantitative assay of diclofenac in biological material by gas-liquid chromatography | |
| Quantitative assay of diclofenac in biological material by gas—liquid chromatography | |||
| P478 | volume | 111 |
| Q71397270 | A study of the effect of aspirin on the pharmacokinetics of oral and intravenous diclofenac sodium |
| Q39710223 | Biotransformation of Diclofenac Sodium (Voltaren®) in Animals and in Man.: II. Quantitative determination of the unchanged drug and principal phenolic metabolites, in urine and bile |
| Q53980666 | Characterization of a novel diclofenac metabolite in human urine by capillary gas chromatography-negative chemical ionization mass spectrometry. |
| Q40157661 | Clinical Pharmacokinetics of Non-steroidal Anti-inflammatory Drugs |
| Q41603966 | Clinical pharmacokinetics of diclofenac. Therapeutic insights and pitfalls |
| Q68781210 | Comparative bioavailability of diclofenac hydroxyethylpyrrolidine vs diclofenac sodium in man |
| Q69428522 | Determination of diclofenac in plasma and synovial fluid by high-performance liquid chromatography with electrochemical detection |
| Q34358486 | Diclofenac concentrations in synovial fluid and plasma after cutaneous application in inflammatory and degenerative joint disease |
| Q39642160 | Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy |
| Q34712798 | Diclofenac sodium: a review of its pharmacological properties and therapeutic use in rheumatic diseases and pain of varying origin |
| Q36660298 | Dissociation between the antinociceptive and anti-inflammatory effects of the nonsteroidal anti-inflammatory drugs. A survey of their analgesic efficacy |
| Q44602058 | Formation of an artifact of diclofenac during acidic extraction of environmental water samples |
| Q68884082 | High-performance liquid chromatographic method for the determination of diclofenac and its hydroxy metabolites in human plasma and urine |
| Q71269609 | Improved gas chromatographic method of determining diclofenac in plasma |
| Q40549577 | Pharmacokinetic Studies on Diclofenac Sodium in Young and Old Volunteers |
| Q39615797 | Pharmacokinetics and Metabolism of the Anti-Inflammatory Agent Voltaren |
| Q67888151 | Pharmacokinetics and bioavailability of diclofenac in the rat |
| Q72084107 | Pharmacokinetics of Diclofenac and Misoprostol When Administered Alone or as a Combination Product |
| Q71044416 | Simultaneous determination of diclofenac sodium and its hydroxy metabolites by capillary column gas chromatography with electron-capture detection |
| Q35669697 | Single intramuscular injection of diclofenac sodium in febrile pediatric patients |
| Q51655965 | The influence of food on the absorption of diclofenac after single and multiple oral doses. |
| Q51655959 | The influence of food on the absorption of diclofenac as determined by the urinary excretion of the unchanged drug and its major metabolites during chronic administration. |
| Q66985119 | The pharmacokinetics of diclofenac sodium following intravenous and oral administration |
| Q70272390 | The pharmacokinetics of diclofenac sodium in patients with active rheumatoid disease |
| Q34322112 | Topical diclofenac epolamine patch 1.3% for treatment of acute pain caused by soft tissue injury |
| Q34708791 | Treatment of Juvenile Rheumatoid Arthritis with Diclofenac Sodium |
Search more.